Skip to main content

Ardent’s DIY CBD Products Safe, Economical For Seniors

The FDA’s recent warnings on CBD will probably not significantly impact the popularity of these products among older adults. For those who have finally found something effective for treating their aches and pains, they are not likely to give that up so fast.  

That said, there is a genuine concern over CBD products that don’t match up to the contents on their labels. Counterfeit CBD products are rampant, and when buying CBD, you get what you pay for. Cheaper CBD available on-line can be tempting for older adults who often have limited resources. But these are just the “bargains” that don’t pay off.

DIY CBD

ardent

Ardent Nova, Silicon Sleeve, Filter

Ardent

Making your own CBD and other cannabis-based medicines is a way to maintain control over the quality of the end-product. But it can also translate into significant cost-savings. And for older adults on a budget, their quality of life could depend on that.

But how practical is it to actually make your own cannabis medicine? As a Baby Boomer and caregiver to elder parents, I wanted to see for myself.

In most cases, making medicine using cannabis begins with activating the plant material. This process can be done on a baking sheet in the oven, at one end of the spectrum, or in a sophisticated processing machine, on the other. For older adults, who can be both forgetful and techno-phobic, I believe that a middle-ground solution is best.

I chose the Ardent Nova because it is automated enough to eliminate the possibility of burning the raw material, yet simple enough for the most technology-challenged senior.

Added value for seniors

Ardent’s founder, Shanel Lindsay has been using cannabis medicine to treat chronic pain for over twenty years. Wanting to take control over the process, Lindsay took a deep dive into the kitchen-arts of concocting her own medical marijuana. But she found that her oven and crock-pot system wasn’t as accurate or efficient as it could be. She also knew that, while her elderly relatives would surely benefit from cannabis medicine, they would never be able to use those methods to produce it on their own.

ardent

Ardent Founder Shanel Lindsay

ardent

In 2015, Lindsay established Ardent to offer a solution that not only addressed these drawbacks, but brought important added value, particularly for older adults. The Nova system is compact, versatile, odorless, and easy to use. Using a uniformly heated, sensor- and algorithm-controlled chamber, the Nova is also capable of extracting almost 90% of medicinal cannabinoids, which means that less raw material can produce more medicine.

Not surprisingly, results of a recent user survey conducted by the company revealed that almost half are 55+.  

Starting with Flower

Purchasing raw flower in a dispensary is the best way to get exactly the cannabinoid profile for your desired medicine. Sourcing your raw material from a dispensary also assures that the product is tested for contaminants. And because it has undergone the least amount of processing, flower is generally the most economical form of cannabis medicine.

But older adults are less likely to want to inhale their medicine, and tend to prefer tinctures or topicals. The Nova is ideally suited for both these delivery methods.

I wanted to make a CBD oil-based tincture, so I chose a Charlotte’s Web Harle-Tsu chemotype containing 21% CBD. One gram, purchased at Washington, DC’s National Holistic Dispensary, cost $13.

A single button

The process of applying heat to the medicinal cannabinoids to convert them into an activated form – called decarboxylation – is where the Nova excels. But as sophisticated as the heating process is, for the user, it is a matter of pressing a single button.

I loaded my gram of flower into the Nova, which looks like a chunky coffee thermos, turned it on, and forgot about it. Ninety minutes later, the red light on the device turned green. Inside the chamber, the flower was ready to be infused into oil.

The Nova makes that process simple as well. I put the decarboxylated flower into a silicon sheath (not included with the core system) that fits into the chamber, then covered it with 2 ounces of extra-virgin olive oil. The same process was repeated, but this time, the finished product was oil infused with almost 90% of the original cannabinoids in the raw material.

My 21% CBD flower produced an oil with almost 200 mg. of CBD, ready to be used as a tincture. Using coconut oil instead of olive oil, the same system easily produces a topical salve.

At $210, (and $20 for the silicon sheath) the Nova is an investment. But for someone who anticipates using medical cannabis for the foreseeable future, it may quickly pay for itself.

And for older adults who have discovered CBD or other types of cannabis medicine, the Ardent Nova would make an excellent holiday gift.

Doing the math

As easy as it is to produce your medicine, I found that figuring out the actual cannabinoid content by volume to be very confusing. Converting from percentages to milligrams, and ounces to milliliters was an onerous process – but this is a problem that is endemic to cannabis-based tinctures. However, the Ardent customer support service is dedicated and helpful. The website is also full of creative ways to use the system.

Decarboxylation Made Easy – Activate THC and CBD | Ardent Cannabis

Ardent Cannabis

Original Article Source: https://www.forbes.com/sites/abbierosner/2019/11/29/ardents-diy-cbd-products-safe-economical-for-seniors/

Comments

Popular posts from this blog

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

A Dozen US Governors Ask Congressional Leaders To Back Federal Marijuana Reform

A bipartisan coalition of 12 governors from states that have legalized medical or recreational cannabis  sent a letter to congressional leaders, asking for their support in getting a major marijuana reform bill through the U.S. House and Senate. The governors of California, Colorado, Maryland, Massachusetts, Nevada, New York, North Dakota, Oregon, Pennsylvania, Utah, Vermont and Washington state are backing  the STATES Act  – which would codify in federal law that marijuana regulations are to be left to the states instead of the federal government – while also seeking protections on banking and tax issues for the MJ industry. “The STATES Act is not about whether marijuana should be legal or illegal; it is about respecting the authority of states to act, lead and respond to the evolving needs and attitudes of their citizens,” the governors wrote. The letter also expressed support for the SAFE Banking Act , which was approved in March by a House committee. Tha...

Cannabis Watch: Canopy Growth To Book Charge Of Up To $568 Million As Marijuana Restructuring Continues

Canopy Growth Corp. said early Thursday it was halting a range of operations across three continents and expects its restructuring plans to result in a charge of up to C$800 million (567.9 million) in the fiscal fourth quarter. U.S.-traded shares US:CGC CA:WEED of the cannabis company fell 1.9% in afternoon trading. Canopy said it was selling operations in Africa, curtailing cultivation of hemp in the U.S. and Columbia, and shutting down an indoor production facility in Canada. The announcement will result in 85 job cuts, the company said. “When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn,” Canopy Chief Executive David Klein said in a statement. Read: As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm Canopy’s restructuring announcement was expected by investors, Cowen analyst Vivien Azer wrote in a note to clients Thursday. Azer rate...